Do pharmacists' presence on rounding teams reduce preventable adverse drug events in hospital general medical units?

February 2004
CMAJ: Canadian Medical Association Journal;2/3/2004, Vol. 170 Issue 3, p333
Academic Journal
Discusses a study which determined whether the presence of pharmacists on rounding teams reduce preventable adverse drug events in hospital general medical units. Research design; Results of the study; Benefits of the presence of pharmacists; Comparison of the efficacy of the presence of a pharmacist on a rounding team with the efficacy of a computerized physician order entry; Barriers to including pharmacists in rounding teams.


Related Articles

  • If You Experience Any of These Symptoms�. Cadley, John // Toastmaster;May2011, Vol. 77 Issue 5, p19 

    The author offers his insights on the side effects of drugs. He says that there is usually one benefit of drugs and thousands of risks. He comments on the common phrases of pharmacists and physicians whether one is allergic to things like naproxen and tamsulosin and whether one's family has ever...

  • Pharmaceutical Consultation in UAE Community Pharmacies. Hamoudi, N. M.; Shirwaikar, A. A.; Ali, H. S.; Al Ayoubi, E. I. // Indian Journal of Pharmaceutical Sciences;Jul/Aug2011, Vol. 73 Issue 4, p404 

    In recent years, the focus of pharmacists as traditional drug dispensers has shifted to more active and participative role in risk assessment, risk management, and other medication related consultation activities. Pharmacy profession is evolving steadily in the United Arab Emirates (UAE)....

  • Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey. Stanek, E J; Sanders, C L; Taber, K A Johansen; Khalid, M; Patel, A; Verbrugge, R R; Agatep, B C; Aubert, R E; Epstein, R S; Frueh, F W // Clinical Pharmacology & Therapeutics;Mar2012, Vol. 91 Issue 3, p450 

    To develop a benchmark measure of US physicians' level of knowledge and extent of use of pharmacogenomic testing, we conducted an anonymous, cross-sectional, fax-based, national survey. Of 397,832 physicians receiving the survey questionnaire, 10,303 (3%) completed and returned it; the...

  • Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia. Lam, Masha S. H.; Cheung, Nathan // Journal of Oncology Pharmacy Practice;Dec2016, Vol. 22 Issue 6, p741 

    Background Studies have identified non-adherence as one of the major contributing factors to treatment failure in chronic myelogenous leukemia (CML) patients receiving imatinib. Published literature has demonstrated a unique role of oncology pharmacists, as part of a multidisciplinary team, in...

  • Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal. Herdeiro, Maria T.; Figueiras, Adolfo; Polónia, Jorge; Gestal-Otero, J J; Polónia, Jorge // Drug Safety;2006, Vol. 29 Issue 4, p331 

    INTRODUCTION: Pharmacists can play a fundamental role in adverse drug reaction (ADR) reporting, although the factors that affect underreporting among these professionals are unknown. The objectives of this study were to identify (i) professional or demographic characteristics; and (ii)...

  • Your liability in filling Rxs correctly. Dinardo, John E. // Drug Topics;6/19/2006, Vol. 150 Issue 12, p30 

    The article presents a question and answer related to pharmacy in the U.S. Someone has asked whether a pharmacist can be held liable for filling a correct prescription. An expert in the field provided an answer stressing that filling a prescription correctly can make the pharmacist liable for it...

  • Collaboration between doctors and pharmacists in the community. Rigby, Debbie // Australian Prescriber;Dec2010, Vol. 33 Issue 6, p191 

    The role of pharmacists is expanding in primary care. There is evidence that greater collaboration between general practitioners and pharmacists can improve patient care. Medication reviews are an example of how pharmacists can assist general practitioners. Joint training and co-location of...

  • Evaluation of a complex intervention for changing professional behaviour: the Evidence Based Out Reach (EBOR) Trial. Nazareth, Irwin; Freemantle, Nick; Duggan, Catherine; Mason, James; Haines, Andy // Journal of Health Services Research & Policy;Oct2002, Vol. 7 Issue 4, p230 

    Objectives: To identify the effect of a complex intervention (educational outreach visits by pharmacists) designed to change general practitioners' (GPs') prescribing on each step of a hypothesised pathway of change leading to the final primary trial outcome of change in prescribing. Method: The...

  • Clinical pharmacists’ interventions in a German University Hospital.  // Pharmacy World & Science;Apr2010, Vol. 32 Issue 2, p194 

    Objective To evaluate pharmaceutical interventions by ward-based clinical pharmacists in Germany. Setting Two ward-based clinical pharmacists working at the Departments of Stem Cell Transplantation and Intensive Care Medicine. Methods Pharmaceutical interventions during ward rounds from December...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics